Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
How might focusing on BMI as a measure of obesity and health overlook other key factors contributing to cardiometabolic risks, and what alternative metrics could provide a more comprehensive evaluation
HIGH-POTENCY ZINC SUPPORT: Formulated with a strong dose of zinc per serving to help support immune function, skin health, and overall wellness
Collagen peptides show the most robust evidence when combined with resistance training, while growth hormone-releasing peptides demonstrate modest effects
Reactive sulfur species and protein persulfidation: an emerging redox axis in human health and disease